🇺🇸 FDA
Patent

US 11648209

Compositions and methods for organ specific delivery of nucleic acids

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 11648209 (Compositions and methods for organ specific delivery of nucleic acids) held by The Board of Regents of the University of Texas System expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/6907, A61K47/6929